title: Advances in diabetic management: implications for anesthesia.
abstract: The past 20 yr have seen an explosion in advances for the management of Type I diabetes mellitus. Not only new delivery systems, such as the continuous subcutaneous insulin pump, but also better and more stable types of insulin with predictable pharmacokinetics and pharmacodynamics have been developed. An artificial pancreas is now on the horizon. This progress has had a significant impact on modern perioperative care of the diabetic patient.
authors.affiliation: *Children's Hospital of Michigan, Detroit, Michigan; †Barbara Davis Center for Childhood Diabetes; ‡Department of Endocrinology, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center; and ¶Department of Anesthesiology, The Children's Hospital, University of Colorado Health Sciences Center, Denver, Colorado.
authors.forename: Zulfiqar
authors.initials: Z
authors.lastname: Ahmed
authors.forename: Charles H
authors.initials: CH
authors.lastname: Lockhart
authors.forename: Molly
authors.initials: M
authors.lastname: Weiner
authors.forename: Georgiana
authors.initials: G
authors.lastname: Klingensmith
mesh_terms: D000758:Anesthesia / Q000379:methods*; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems
chemical_list: D007328:Insulin
references.citation: Masharani U. Diabetes mellitus &hypoglycemia. In: Tiernet LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis &Treatment. New York: McGraw-Hill, 2004:1146–91.
references.citation: Unger RH, Foster DW. Diabetes mellitus. In: Tiernet LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis &Treatment. New York: McGraw-Hill, 2004:1029–40.
references.citation: Cryer PE, Polonsky KS. Glucose homeostasis and hypoglycemia. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia: WB Saunders, 1998:962–3.
references.citation: Roper NA, Bilous RW. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog). Diabet Med 1998;15:1063–4.
references.citation: Lorenz RA. Modern insulin therapy for type 1 diabetes mellitus. Prim Care 1999;26:917–29.
references.citation: Campbell RW, White JR, Levien T, Baker D. Insulin glargine. Clin Ther 2001;23:1938–57.
references.citation: Levien TL, Baker DE, White JR Jr., Campbell RK. Insulin glargine: a new basal insulin. Ann Pharmacother 2002;36:1019–27.
references.citation: Maniatis AK, Klingensmith GL, et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001;107:351–6.
references.citation: Meece JD, Campbell RK. Insulin lispro update. Diabetes Educ 2002;28:269–77.
references.citation: Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA. Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial. Diabetes Care 2001;24:1556–9.
references.citation: Selam JL. Development of implantable insulin lumps: long is the road. Diabet Med 1988;5:724–33.
references.citation: Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001;107:222–6.
references.citation: Sun R, Klein KW, White PF. The effect of timing on ondansetron administration in outpatients undergoing otolaryngologic surgery. Anesth Analg 1997;84:331–6.